266 related articles for article (PubMed ID: 23205838)
1. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
Angoa-Pérez M; Kane MJ; Briggs DI; Francescutti DM; Sykes CE; Shah MM; Thomas DM; Kuhn DM
J Neurochem; 2013 Apr; 125(1):102-10. PubMed ID: 23205838
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
3. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
Angoa-Pérez M; Kane MJ; Herrera-Mundo N; Francescutti DM; Kuhn DM
Life Sci; 2014 Feb; 97(1):31-6. PubMed ID: 23892197
[TBL] [Abstract][Full Text] [Related]
4. Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.
Angoa-Pérez M; Kane MJ; Francescutti DM; Sykes KE; Shah MM; Mohammed AM; Thomas DM; Kuhn DM
J Neurochem; 2012 Mar; 120(6):1097-107. PubMed ID: 22191803
[TBL] [Abstract][Full Text] [Related]
5. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.
Thomas DM; Angoa Pérez M; Francescutti-Verbeem DM; Shah MM; Kuhn DM
J Neurochem; 2010 Nov; 115(3):595-605. PubMed ID: 20722968
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between hypothermia and neurotoxicity caused by mephedrone and methcathinone in TPH2 knockout mice.
Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
Psychopharmacology (Berl); 2019 Mar; 236(3):1097-1106. PubMed ID: 30074064
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
9. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.
Hadlock GC; Webb KM; McFadden LM; Chu PW; Ellis JD; Allen SC; Andrenyak DM; Vieira-Brock PL; German CL; Conrad KM; Hoonakker AJ; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2011 Nov; 339(2):530-6. PubMed ID: 21810934
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the Influence of Two Structural Substituents on the Differential Neurotoxic Effects of Acute Methamphetamine and Mephedrone Treatment on Dopamine Nerve Endings with the Use of 4-Methylmethamphetamine and Methcathinone.
Anneken JH; Angoa-Pérez M; Sati GC; Crich D; Kuhn DM
J Pharmacol Exp Ther; 2017 Mar; 360(3):417-423. PubMed ID: 28039330
[TBL] [Abstract][Full Text] [Related]
11. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.
Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
Neuropharmacology; 2018 May; 134(Pt A):46-56. PubMed ID: 28851615
[TBL] [Abstract][Full Text] [Related]
12. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
13. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.
Kehr J; Ichinose F; Yoshitake S; Goiny M; Sievertsson T; Nyberg F; Yoshitake T
Br J Pharmacol; 2011 Dec; 164(8):1949-58. PubMed ID: 21615721
[TBL] [Abstract][Full Text] [Related]
14. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
Baucum AJ; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
J Neurosci; 2004 Mar; 24(13):3436-43. PubMed ID: 15056723
[TBL] [Abstract][Full Text] [Related]
16. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
Miller DB; O'Callaghan JP
Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961
[TBL] [Abstract][Full Text] [Related]
17. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2008 May; 105(3):605-16. PubMed ID: 18088364
[TBL] [Abstract][Full Text] [Related]
18. Effect of Some Psychoactive Drugs Used as 'Legal Highs' on Brain Neurotransmitters.
Gołembiowska K; Jurczak A; Kamińska K; Noworyta-Sokołowska K; Górska A
Neurotox Res; 2016 Apr; 29(3):394-407. PubMed ID: 26501352
[TBL] [Abstract][Full Text] [Related]
19. D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice.
Granado N; Ares-Santos S; Moratalla R
Neurotox Res; 2014 Jan; 25(1):100-9. PubMed ID: 24257898
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.
Halpin LE; Collins SA; Yamamoto BK
Life Sci; 2014 Feb; 97(1):37-44. PubMed ID: 23892199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
